10x Genomics/ US88025U1097 /
2024-04-25 5:35:28 PM | Chg. -0.97 | Volume | Bid- | Ask5:37:27 PM | High | Low |
---|---|---|---|---|---|---|
26.56USD | -3.51% | 9,431 Turnover: 250,858.16 |
-Bid Size: - | 26.56Ask Size: 100 | 27.12 | 26.32 |
GlobeNewswire
03-14
Johnson Fistel Announces Investigation of 10x Genomics (TXG) for Potential Securities Law Violations
GlobeNewswire
01-30
Johnson Fistel Announces Investigation of 10x Genomics (TXG) for Potential Securities Law Violations
GlobeNewswire
2022-03-28
Fluidigm Highlights the Strategic Capital Infusion by Casdin Capital and Viking Global as the Only A...
GlobeNewswire
2021-08-31
10x Genomics to Present at the Morgan Stanley 19th Annual Global Healthcare Conference
GlobeNewswire
2021-08-06
10x Genomics to Present at the UBS Genomics 2.0 and MedTech Innovations Summit
GlobeNewswire
2021-06-10
10x Genomics Unlocks Whole Transcriptome Analysis in FFPE Tissues With New Visium Assay, Now Shippin...
GlobeNewswire
2021-04-29
10x Genomics to Present at the BofA Securities 2021 Virtual Healthcare Conference
GlobeNewswire
2021-04-01
10x Genomics Puts Single Cell Analysis Within Reach of All With Low Throughput Gene Expression Kit
GlobeNewswire
2021-03-09
10x Genomics Expands Pleasanton Headquarters with New Facilities at Two Locations
GlobeNewswire
2021-02-24
10x Genomics Showcases Next Wave of Innovations at First Ever Xperience Event
GlobeNewswire
2021-02-23
Psomagen, Inc. Expands Precision Genomics Capabilities with 10x Genomics’ Single Cell Sequencing Tec...
GlobeNewswire
2021-02-17
10x Genomics Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Outlook for 20...
GlobeNewswire
2021-01-28
10x Genomics to Report Fourth Quarter and Full Year 2020 Financial Results on February 17, 2021